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Introduction 
 
Current methodology has made popular the pragmatic randomized trial (Foster & Little, 
2012) and has led to an acknowledged growth of high-quality research in the‘new 
generation’ of psychosocial interventions in dementia care (Orrell, 2012). However, many 
trials of psychosocial interventions in dementia lack impact. It is not clear whether this 
reflects a genuine ineffectiveness, since the methodology used in dementia care research is 
at resent weak in addressing the important distinction between genuine ineffectiveness and 
an implementation error. Therefore, potentially effective dementia care interventions that 
may have a positive impact on patient experience can fail to show effectiveness, thereby 
reducing treatment options and wasting research money. 
 
Methodological discussions about the success and failure of interventions in dementia care 
within the European INTERDEM group of multi-professional researchers on psychosocial 
dementia care (www.interdem.org/) led to acritical analysis of the suitability of the current 
methodology.  This has often relied on the Medical Research Council’s (MRC) Framework 
for complex interventions and its iterations (Campbell et al., 2000; Craig et al., 2008; Craig & 
Petticrew, 2013). Foster and Little (2012) pinpoint an important obstacle to improving clinical 
practice as the legacy of ‘simple’ drug therapy evaluations which are engrained in the design 
and conduct of the pragmatic trial, a view that can also be extended more generally to the 
interpretation and conduct of the MRC framework for complex interventions and its 
methodologies.  The advantage of pragmatic trials is their proximity to daily practice in 
routine health care settings. This has particular implications for the design and conduct of 
psychosocial intervention research in dementia, where the important distinction between 
poor attention to implementation and genuine ineffectiveness is often overlooked. 
 
Furthermore, better attention to the implications of this proximity in the design and conduct of 
psychosocial intervention research trials may reduce the need for a separate large-scale 
implementation study phase in the way that this is currently conceived within the MRC 
approach to complex interventions (Craig et al., 2008; Craig & Petticrew, 2013). 
 
This is an urgent issue for psychosocial intervention research in dementia care as today 35.6 
million people and families worldwide live with dementia (Prince et al., 2013), whilst major 
pharmaceutical advances in prevention and cure remain elusive (Miller, 2012). The predicted 
future growth of dementia cases over the next decade will undoubtedly raise the already 
high costs of care, estimated at US$ 604 billion in 2010 (Wimo et al., 2013), in an illness that 
is most feared people over the age of 55 years (Le Couteur, Doust, Creasey, & Brayne, 
2013), since it can undermine core human capacities resulting in decline in quality of life 
(Selkoe, 2012). Although cure for dementia is not available for dementia patients, we are not 
empty handed. Psychosocial intervention research has emerged as today’s forerunner, 
given its aim to improve daily practice among  professionals who provide support to people 
and families living with dementia. Psychosocial interventions in dementia involve interactions 
between people to improve psychological and social functioning (Moniz-Cook, Vernooij-
Dassen, Woods, & Orrell, 2011; Rabins et al., 2007), such as cognitive stimulation therapy 
(Woods, Aguirre, Spector, & Orrell, 2012), occupational therapy (Graff et al., 2006) and 
support programmes for family carers (Vernooij-Dassen, Draskovic, McCleery, & Downs, 
2011). 
 
This paper outlines the rationale for a paradigm shift in the design and methodology for 
evaluation of complex interventions in applied dementia care research. We use psychosocial 
intervention research as an exemplar of how researchers and their funders may achieve 
better value for money. 
 
Success and failure of psychosocial interventions 
 
Psychosocial interventions are most effective when tailored to the individual needs of the 
person and family (Olazaran et al., 2010). Positive effects are demonstrated on patient 
cognition (effect size 0.59, n ¼ 67), patient behaviour (effect size 0.60, n ¼ 62) (Olazaran et 
al., 2010) and family carer mood (effect size _0.66, n ¼ 294) (Vernooij-Dassen, Draskovic, 
et al., 2011). Moreover, they reduce costs by delaying institutionalization (effect size OR 
0.59, 95% BI 0.43–0.81) (Spijker et al., 2008). However, many studies fail to report positive 
outcomes (Olazaran et al., 2010). For example, recent pragmatic trials of support 
programmes (Kurz et al., 2012; Low et al., 2013; Van de Ven et al., 2013; Waldorff et al., 
2012), telecare (Bardsley, Steventon, & Doll, 2013), training interventions (Beer et al., 2011; 
Spijker et al., 2011) and system enhancements or novel methods of delivering services 
(Goldberg et al., 2013; Meeuwsen et al., 2012; Nourhashemi et al., 2010; Van Houdt & De 
Lepeleire, 2010) all report no positive effects compared with the control ‘usual care’ 
condition. One study nonetheless demonstrated improvements in the patient experience and 
family carer satisfaction (Goldberg et al., 2013) whilst others point to problems with delivery 
of the intervention by practitioners such as poor adherence and variation in practice (Low et 
al., 2013; Spijker et al., 2013; Wenborn et al., 2013). Thus, failure to report positive 
outcomes may reflect genuine ineffectiveness where the intervention has failed to address 
basic human values such as dignity and autonomy (Vernooij-Dassen, Leatherman, & 
Rikkert, 2011) or may be a consequence of practical difficulties in conducting applied 
research in routine care settings (Iliffe et al., 2008). This latter phenomenon is known as an 
implementation error which refers to low treatment fidelity, meaning that the application of 
the intervention differs considerably from the original plan (Hulscher, Laurant, & Grol, 2005). 
 
The weakness in current methodologies for evaluation can be observed where an 
implementation error is overlooked during pragmatic trials of effectiveness. A particular 
aspect that is often ignored is the importance of the practitioners who deliver interventions. 
The world of health care professionals, with their multiple and competing demands within 
routine care settings, has obvious impacts on treatment fidelity and the assumption that 
interventions are always carried out to plan is at best, naive. To establish how research can 
do more for today’s dementia patients and families, better knowledge is required about 
treatment fidelity including the interactions of practitioners with people with dementia and 
families and the way they deliver the intervention. 
 
Treatment fidelity 
 
Randomized and cluster randomized control trial (RCT or cRCT) designs have improved the 
standards and quality of psychosocial intervention research. They focus on minimizing the 
risk of type I (rejection of a null hypothesis that is in fact correct) and type II (acceptance of a 
null hypothesis that is in reality false) errors, but rarely on problems of fidelity to the 
intervention protocol. Reporting of fidelity has been weak (Turner, Shamseer, Altman, 
Schulz, & Moher, 2012) and where this has been reported, treatment fidelity varies from 18% 
to 100% (Perry et al., 2011). This introduces the risk of an implementation error. 
Implementation science places an implementation error as equivalent to type I and II errors, 
naming this ‘the type III error’ (Hulscher et al., 2005). Implementation errors threaten internal 
validity and undermine the credibility of an otherwise successful intervention, thus rendering 
effect analyses and positive outcomes meaningless (Moniz-Cook et al., 2008), with 
associated wasted effort and resources (Glasgow, Klesges, Dzewaltowski, Estabrooks, & 
Vogt, 2006). 
 
Explaining variation in fidelity goes some way towards minimizing type III errors. Variation 
may relate to the level of control over the intervention. Zwarenstein and colleagues 
(Zwarenstein et al., 2008) outline two types of trials where the control of setting and 
treatment fidelity is crucial: explanatory (high control) and pragmatic (low control) trials. 
Explanatory trials demonstrate efficacy or potential (in) effectiveness of an intervention in an 
‘ideal setting with a closely monitored intervention, whilst pragmatic trials inform us about the 
effectiveness, in the context of daily practice. An example of high control over delivery of the 
intervention is seen in a recent study of a successful family care support programme where 
practitioners were recruited to deliver the intervention, with no other apparent competing 
demands. The authors outline a procedure for regular clinical supervision of practitioners 
with systematic ongoing attention to poor fidelity (Livingston et al., 2013). 
 
Conducting psychosocial intervention research in dementia care requires improved clarity of 
methods that properly address levels of control over the intervention when delivered by the 
growing range of practitioners including health and social care professionals. For example, 
the landmark review of non-pharmacological therapy in dementia demonstrates that effective 
studies were highly controlled and used a limited number of welltrained practitioners 
(interventionists) combined with monitoring or team-based social control (Olazaran et al., 
2010).. Moreover, explanatory trials carried out by a limited number of interventionists with 
strict application of the intervention protocol demonstrate strong positive effects, whilst 
pragmatic trials of a similar intervention delivered by numerous interventionists with poor 
treatment fidelity fail to demonstrate equivalent outcomes (Graff et al., 2006; Voigt-Radloff et 
al., 2011). 
 
Why is treatment fidelity low? Studies of barriers to treatment fidelity within RCTs provide 
some clues. These highlight the importance of accounting for the context of daily practice 
including: patient characteristics (Voigt-Radloff et al., 2011); time constraints, motivation and 
opportunity for shared decision making by professionals (Spijker et al., 2013); the social 
setting (Spijker et al., 2013); the economic and organizational context; and use of 
implementation strategies (Leontjevas et al., 2013; Spijker et al., 2013; Voigt-Radloff et al., 
2011). A striking finding is that barriers noted in pragmatic trials are similar to those found in 
implementation studies (Grol, Wensing, Eccles, & Davis, 2013). 
 
 
There is a growing interest in the contribution of implementation science to applied research 
in health care, although at present this appears to be limited to outlining the range of 
strategies that are available to the researcher (Peters, Adam, Alonge, Agyepong, & Tran, 
2013). We suggest that psychosocial intervention research can benefit from knowledge 
derived from implementation studies. Topics in implementation science can be emphasized 
early in the MRC framework, by an improved association between the developmental and 
feasibility testing phase, where the latter could include aspects of: treatment fidelity; 
practitioner behaviour; and potential contextual factors that may help or hamper delivery of 
the intervention. Single-case studies at the developmental phase are a good example of 
where the researcher can test the success and failure of an intervention (Moniz-Cook, 
Woods, & Richards, 2001). However, this would be of little practical use if the feasibility and 
pilot studies do not then include methods to address identified contextual factors in order 
to overcome the obstacles and reinforce facilitators in the delivery of the intervention. Only 
then can the evaluation phase be embarked upon. 
 
In order to avoid the type III implementation error in the evaluation phase, we propose a 
paradigm shift in the design of studies at the evaluation and implementation phases of 
complex interventions. This can be achieved at the evaluation phase by studies that first test 
the efficacy of an intervention and then its effectiveness (see Table 1). 
 
 
Table 1.  a refined methodology for complex psychosocial intervention research trials. 
 
MRC 2013 Refined methodology 
  
Developmental 
 Identifying the evidence base 
 Identifying or developing theory 
 Modelling process and 
outcomes  
Developmental 
 No change 
Feasibility and piloting 
 Testing procedures 
 Estimating recruitment and 
retention 
 Determining sample size 
Feasibility and piloting  
 Analyse practical issues such as practitioner behaviour and 
contextual factors noted in modelling process and outcomes that may 
help or hamper delivery of the intervention 
 Testing procedures 
 Estimating recruitment and retention  
 Determining sample size 
Evaluation 
Assessing effectiveness 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Understanding change process 
 
Assessing of cost effectiveness 
 
Evaluation 
Assessing efficacy – explanatory trial 
 ‘Ideal setting(s)’ – motivated practitioners, patients and services 
 Anticipated barriers and facilitators prior to intervention by 
stakeholders (service managers, professionals and patients) 
 Testing of strategies to stimulate the use of the intervention 
 Highly controlled by monitoring use of intervention 
 Evaluation of barriers and facilitators perceived by – dissemination 
implicit in the procedure 
 Controlled or randomized controlled trial (RCT) 
Evaluation of effectiveness – pragmatic trial 
 Analysis of stakeholders – dissemination implicit 
 Identification of anticipated barriers and facilitators 
 Contextualizing intervention to stakeholders 
 Use of strategies to overcome barriers 
 Training of practitioners 
 RCT or cluster RCT 
 Surveillance, monitoring, follow-up if possible 
Understanding change process 
 ‘Ideal setting(s)’ – motivated practitioners, patients and services 
Assessing of cost effectiveness 
 
Implementation 
 Dissemination 
 Surveillance and monitoring 
 Long-term follow-up 
Implementation 
 Implementation methodology already included in pragmatic trial 
 Dissemination of intervention and strategies to stimulate widespread 
use of the intervention according to its protocol 
 Surveillance, monitoring and audit included in dissemination 
Developmental 
 Identifying the evidence base 
 Identifying the developing 
theory 
 Modelling process and 
outcomes 
Developmental 
 Use theory to understand findings for stakeholders or services 
settings where the intervention was weak (eg use drop out data, 
patient views, poor outcomes etc.) 
 Development of new innovation considering previous barriers 
 Modelling process and outcomes. 
 
 
Where next? 
 
In contrast to the MRC framework we suggest that researchers should precede a pragmatic 
trial with a well designed explanatory trial in which the mechanisms for practitioner behaviour 
are highly controlled and studied. This has the advantage of minimizing type III errors by 
introducing implementation methodology at the preliminary trial phase (Table 1). Here, 
implementation methodology can guide careful study of the process of delivery of an 
intervention including: the ‘ideal’ setting where motivated target stakeholders (such as 
practitioners, patients, families and service providers) have been selected; study of 
anticipated barriers and facilitators outlined by participating stakeholders prior to the 
intervention; and testing of strategies to facilitate intervention uptake (such as leadership, 
supervision and stakeholder engagement). Strategies such as preparatory practice activity to 
train interventionists in delivery of the intervention can also be tested (Borrelli, 2011) to 
determine what level of monitoring will be needed to enhance fidelity and changes in 
practitioner practice in the final large-scale trial, which ideally should be widespread and 
consider cluster designs. The recent notion of an effectiveness-implementation hybrid design 
(Curran, Bauer, Mittman, Pyne, & Stetler, 2012) also emphasizes the importance of including 
implementation strategies within a final large-scale ‘pragmatic’ trial, but this type of design 
continues to overlook the need for systematic study of the practical barriers experienced by 
stakeholders in their own varied settings and contexts.  These need to be properly 
understood in detail before strategies to overcome these can be identified. We suggest that 
stakeholder views and behaviour are important and should be studied first during the 
explanatory trial, prior and after the intervention. Guidance on how to assess clinical 
governance and intervention fidelity to enable researchers to improve rigour (Charlesworth, 
Burnell, Hoe, Orrell, & Russell, 2013) can also be used at this stage. Moreover, the 
researcher also has the opportunity for more detailed study of patient adherence and drop 
out which may allow for better targeting of individualized interventions through examination 
of socio-cultural factors, co-morbid health conditions, timing (i.e. when in the patient journey 
the intervention was offered), suitability of the intervention to particular patients and families 
as well as contextual factors such as what other support might be available in ‘usual care’ 
settings. A controlled – or a randomized controlled trial where randomization is at patient but 
not practitioner level, if this can realistically be powered within a relatively small study – can 
be conducted.  The key would be to use a highly motivated ‘ideal’ group of practitioners and 
supportive management in the experimental group and a ‘normal’ or ‘usual’ control group to 
test the impact (efficacy) of the intervention. 
 
When the impact is positive, researchers can then proceed to the next stage of evaluation 
within an adapted pragmatic randomized (or ideally a cluster randomized) controlled trial. 
This final trial of effectiveness will use implementation research strategies such as starting 
with an analysis of the setting and the stakeholders, identification of anticipated barriers and 
facilitators; adaptations to barriers discovered in the explanatory trial and to the anticipated 
barriers and also methods to strengthen facilitators. These adaptations should be used in the 
training of the practitioners. Implementation methodology may now be used a priori to 
minimize type III errors and also during the trial as a means of monitoring delivery. In this 
way the design of a pragmatic trial may be dynamically harnessed in the real world of 
service provision.  Thus, the pragmatic trial will measure the effect of intervention 
contextualized to practitioner and patient circumstances whilst the accompanying process 
analysis will carefully describe application of the intervention and the extent to which its 
perceived barriers have been overcome and its facilitators strengthened. Within our refined 
paradigm not only does dissemination become an iterative process that implicitly involved 
stakeholders throughout but the second evaluation study which tests effectiveness can 
incorporate methods for surveillance, monitoring, and longer term follow-up, which may in 
turn contribute to future development of related dementia care innovation. 
 
By reducing a layer of enquiry surrounding implementation within the MRC complex 
intervention framework (Craig et al., 2008), the aspiration for research findings to do more 
for patients is facilitated. This paradigm shift is, we suggest, an important avenue for 
efficiency savings in applied dementia care research programmes such as those funded by 
the National Institute of Health Research and the Economic and Social Research Council in 
the UK or the recent European Joint Programme for Neurodegenerative Disease Research  
http://www.neurodegeneration research.eu/). 
 
Conclusion 
 
People with dementia and families today deserve high quality interventions to live well with 
dementia, backed up by wise investment in dementia care research (Selkoe, 2012). Given 
current constraints on budgets and the growing number of people who can benefit from 
psychosocial interventions, practitioners and service organizations deserve timely attention 
to their barriers and facilitators in application of a new intervention. Ignoring the role of 
practitioners who deliver the intervention in their particular contexts will, we suggest, 
continue to overlook the type III error and thus hamper treatment options for people and their 
families. We therefore propose a paradigm shift in methodology for psychosocial research 
where implementation errors are acknowledged and addressed particularly during the 
evaluation phase. This departs from the MRC framework, starting with slightly better 
integration of the developmental (i.e. the modelling of process and outcomes) and feasibility 
phases to include contextual factors and practitioner behaviour in the latter. However we 
propose significant changes at the MRC evaluation phase. Given our objective to 
differentiate between genuine effectiveness and implementation error, we outline how this 
may be achieved with a design that first tests efficacy under highly controlled conditions 
whilst eliciting and studying the variety of practitioner and patient contexts and then, after 
adjusting the intervention to the variety of real life contexts, tests effectiveness of this in daily 
practice. Our paradigm shift future offers opportunities, depending on the findings from the 
‘effectiveness’ study, to render the implementation phase, as it is currently conceived (Craig 
& Petticrew, 2013) redundant, through identifying and application of theory to the findings 
and modelling new innovation. This may accelerate the scope for improved delivery of a 
psychosocial intervention into routine practice. 
 
Acknowledgements 
 
We thank Prof. Dr Marlies Hulscher, Prof. Jill Manthorpe and Prof. Bob Woods for their 
valuable comments. 
 
References 
 
Bardsley, M., Steventon, A., & Doll, H. (2013). Impact of telehealth on general practice 
contacts: Findings from the whole systems demonstrator cluster randomised trial. BMC 
Health Service Research, 13, 395. doi:10.1186/1472-6963-13-395  
 
Beer, C., Horner, B., Flicker, L., Scherer, S., Lautenschlager, N.T., Bretland, N., . . . Almeida, 
O.P. (2011). A cluster-randomised trial of staff education to improve the quality of life of 
people with dementia living in residential care: The DIRECT study. PLoS One, 6(11), 
e28155. doi:10.1371/journal. pone.0028155 
 
Borrelli, B. (2011). The assessment, monitoring, and enhancement of treatment fidelity in 
public health clinical trials. Journal of Public Health Dentistry, 71(1), S52–63. 
 
Campbell, M., Fitzpatrick, R., Haines, A., Kinmonth, A.L., Sandercock, P., Spiegelhalter, D., . 
. . Tyrer, P. (2000). Framework for design and evaluation of complex interventions to 
improve health. British Medical Journal, 321(7262), 694–696. 
 
Charlesworth, G., Burnell, K., Hoe, J., Orrell, M., & Russell, I. (2013). Acceptance checklist 
for clinical effectiveness pilot trials: A systematic approach. BMC Medical Research 
Methodology, 13, 78. doi:10.1186/1471-2288-13-78 
 
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2008). 
Developing and evaluating complex interventions: The new medical research council 
guidance. British Medical Journal, 337, a1655. doi:10.1136/bmj.a1655 
 
Craig, P., & Petticrew, M. (2013). Developing and evaluating complex interventions: 
Reflections on the 2008 MRC guidance. International Journal of Nursing Studies, 50(5), 
585– 587. doi:10.1016/j.ijnurstu.2012.09.009 
 
Curran, G.M., Bauer, M., Mittman, B., Pyne, J.M., & Stetler, C. (2012). Effectiveness-
implementation hybrid designs: Combining elements of clinical effectiveness and 
implementation research to enhance public health impact. Medical Care, 50(3), 217–226. 
doi:10.1097/MLR.0b013e3182408812 
 
Foster, N., & Little, P. (2012). Methodological issues in pragmatic trials of complex 
interventions in primary care. British Journal of General Practice, 62(594), 10–11. 
doi:10.3399/bjgp12_616238 
 
Glasgow, R.E., Klesges, L.M., Dzewaltowski, D.A., Estabrooks, P.A., & Vogt, T.M. (2006). 
Evaluating the impact of health promotion programs: Using the RE-AIM framework to form 
summary measures for decision making involving complex issues. Health Education 
Research, 21(5), 688–694. doi:10.1093/Her/Cyl081 
 
Goldberg, S.E., Bradshaw, L.E., Kearney, F.C., Russell, C., Whittamore, K.H., Foster, P.E., . 
. . Medical Crises in Older People Study Group. (2013). Care in specialist medical and 
mental health unit compared with standard care for older people with cognitive impairment 
admitted to general hospital: Randomised controlled trial (NIHR TEAM trial). British 
Medical Journal, 347, f4132. doi:10.1136/bmj.f4132 
 
Graff, M.J., Vernooij-Dassen, M.J., Thijssen, M., Dekker, J., Hoefnagels, W.H., & Rikkert, 
M.G. (2006). Community based occupational therapy for patients with dementia and their 
care givers: Randomised controlled trial. [Randomized Controlled Trial Research Support, 
Non-U.S. Gov’t]. British Medical Journal, 333(7580), 1196. doi:10.1136/bmj.39001. 
688843.BE 
 
Grol, R., Wensing, M., Eccles, M., & Davis, D. (2013). Improving patient care: The 
implementation of change in health care. Chichester: Wiley-Blackwell. 
 
Hulscher, M., Laurant, M., & Grol, R. (2005). Theories on implementation of change in 
healthcare. In R. Grol, M. Wensing & M. Eccles (Eds.). Improving patient care: The 
Implementation of change in clinical practice (pp. 256– 272). London: Elsevier. 
 
Iliffe, S., Manthorpe, J., Warner, J., Drennan, V., Goodman, C., Rait, G., . . . Kharicha, K. 
(2008). Making progress in psychosocial research in dementia. Dementia, 7(2), 167–174. 
doi:10.1177/1471301208091160 
 
Kurz, A., Thone-Otto, A., Cramer, B., Egert, S., Frolich, L., Gertz, H.J., . . . Werheid, K. 
(2012). CORDIAL: Cognitive rehabilitation and cognitive-behavioral treatment for early 
dementia in Alzheimer disease: A multicenter, randomized, controlled trial. Alzheimer 
Disease and Associated Disorders, 26(3), 246–253. doi:10.1097/ WAD.0b013e318231e46e 
 
Le Couteur, D.G., Doust, J., Creasey, H., & Brayne, C. (2013). Political drive to screen for 
pre-dementia: Not evidence based and ignores the harms of diagnosis. British Medical 
Journal, 347, f5125. 
 
Leontjevas, R., Gerritsen, D.L., Smalbrugge, M., Teerenstra, S., Vernooij-Dassen, M.J., & 
Koopmans, R.T. (2013). A structural multidisciplinary approach to depression management 
in nursing-home residents: A multicentre, stepped-wedge cluster-randomised trial. Lancet, 
381(9885), 2255–2264. doi:S0140-6736(13)60590-5 [pii] 10.1016/S0140-6736(13) 
60590-5 [doi] 
 
Livingston, G., Barber, J., Rapaport, P., Knapp, M., Griffin, M., King, D., . . . Cooper, C. 
(2013). Clinical effectiveness of a manual based coping strategy programme (START, 
STrAtegies for RelaTives) in promoting the mental health of carers of family members with 
dementia: Pragmatic randomised controlled trial. British Medical Journal, 347, f6276. 
doi:10.1136/bmj.f6276 
 
Low, L.F., Brodaty, H., Goodenough, B., Spitzer, P., Bell, J.P., Fleming, R., . . . Chenoweth, 
L. (2013). The Sydney Multisite Intervention of Laughter Bosses and Elder Clowns (SMILE) 
study: Cluster randomised trial of humour therapy in nursing homes. BMJ Open, 3(1). 
doi:10.1136/bmjopen- 2012-002072 
 
Meeuwsen, E.J., Melis, R.J., Van Der Aa, G.C., Goluke- Willemse, G.A., De Leest, B.J., Van 
Raak, F.H., . . . Olde Rikkert, M.G. (2012). Effectiveness of dementia follow-up care by 
memory clinics or general practitioners: Randomised controlled trial. British Medical Journal, 
344, e3086. doi:10.1136/bmj.e3086 
 
Miller, G. (2012). Alzheimer’s research. Stopping Alzheimer’s before it starts. [News]. 
Science, 337(6096), 790–792. doi:10.1126/science.337.6096.790 
 
Moniz-Cook, E., Elston, C., Gardiner, E., Agar, S., Silver, M., Win, T., . . . Wang, M. (2008). 
Can training community mental health nurses to support family carers reduce behavioural 
problems in dementia? An exploratory pragmatic randomised controlled trial. International 
Journal of Geriatric Psychiatry, 23(2), 185–191. doi:10.1002/gps.1860 
 
Moniz-Cook, E., Vernooij-Dassen, M., Woods, B., & Orrell, M. (2011). Psychosocial 
interventions in dementia care research: The INTERDEM manifesto. [Editorial]. Aging and 
Mental Health, 15(3), 283–290. doi:10.1080/13607863. 2010.543665 
 
Moniz-Cook, E., Woods, R.T., & Richards, K. (2001). Functional analysis of challenging 
behaviour in dementia: The 
role of superstition. International Journal of Geriatric Psychiatry, 16(1), 45–56. 
 
Nourhashemi, F., Andrieu, S., Gillette-Guyonnet, S., Giraudeau, B., Cantet, C., Coley, N., . . 
. Group, P. (2010). Effectiveness of a specific care plan in patients with Alzheimer’s disease: 
Cluster randomised trial (PLASA study). British Medical Journal, 340, c2466. 
doi:10.1136/bmj.c2466 
 
Olazaran, J., Reisberg, B., Clare, L., Cruz, I., Pena-Casanova, J., Del Ser, T., . . . Muniz, R. 
(2010). Nonpharmacological therapies in Alzheimer’s disease: A systematic review of 
efficacy. Dementia and Geriatric Cognitive Disorders, 30(2), 161–178. 
doi:10.1159/000316119 
 
Orrell, M. (2012). The new generation of psychosocial interventions for dementia care. 
British Journal of Psychiatry,201(5), 342–343. doi:10.1192/bjp.bp.111.107771 
 
Perry, M., Draskovic, I., Lucassen, P., Vernooij-Dassen, M., van Achterberg, T., & Rikkert, 
M.O. (2011). Effects of educational interventions on primary dementia care: A systematic 
review. [Meta-Analysis Review]. International Journal of Geriatric Psychiatry, 26(1), 1–11. 
doi:10.1002/gps.2479 
 
Peters, D.H., Adam, T., Alonge, O., Agyepong, I.A., & Tran, N. (2013). Implementation 
research: What it is and how to do it. British Medical Journal, 347, f6753. 
doi:10.1136/bmj.f6753 
 
Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., & Ferri, C.P. (2013). The global 
prevalence of dementia: A systematic review and metaanalysis. Alzheimer’s & Dementia, 
9(1), 63–75 e62. doi:10.1016/j.jalz.2012.11.007 
 
Rabins, P.V., Blacker, D., Rovner, B.W., Rummans, T., Schneider, L.S., Tariot, P.N., . . . 
Fochtmann, L.J. (2007). American Psychiatric Association practice guideline for the 
treatment of patients with Alzheimer’s disease and other dementias. Second edition. 
American Journal of Psychiatry, 164(12 Suppl), 5–56. 
 
Selkoe, D.J. (2012). Preventing Alzheimer’s disease. Science, 337(6101), 1488–1492. 
doi:10.1126/science.1228541 
 
Spijker, A., Teerenstra, S., Wollersheim, H., Adang, E., Verhey, F., & Vernooij-Dassen, M. 
(2013). Influence of adherence to a systematic care program for caregivers of dementia 
patients. American Journal of Geriatric Psychiatry, 21(1), 26–36. 
doi:10.1016/j.jagp.2012.10.003 
 
Spijker, A., Vernooij-Dassen, M., Vasse, E., Adang, E., Wollersheim, H., Grol, R., . . . 
Verhey, F. (2008). Effectiveness of nonpharmacological interventions in delaying the 
institutionalization of patients with dementia: A meta-analysis.  Journal of the American 
Geriatrics Society, 56(6), 1116–1128. doi:JGS1705 [pii] 10.1111/j.1532-5415.2008.01705.x 
 
Spijker, A., Wollersheim, H., Teerenstra, S., Graff, M., Adang, E., Verhey, F., . . . Vernooij-
Dassen, M. (2011). Systematic care for caregivers of patients with dementia: A multicenter, 
cluster-randomized, controlled trial. American Journal of Geriatric Psychiatry, 19(6), 521–
531. doi:10.1097/JGP. 0b013e3182110599 
 
Turner, L., Shamseer, L., Altman, D.G., Schulz, K.F., & Moher, D. (2012). Does use of the 
CONSORT Statement impact the completeness of reporting of randomised controlled trials 
published in medical journals? A Cochrane review. Systems Review, 1, 60. doi:2046-4053-1-
60 [pii] 10.1186/2046- 4053-1-60 [doi] 
 
Van de Ven, G., Draskovic, I., Adang, E.M., Donders, R., Zuidema, S.U., Koopmans, R.T., 
Vernooij-Dassen, M.J. (2013). Effects of dementia-care mapping on residents and staff of 
care homes: A pragmatic cluster-randomised controlled trial. PLoS One, 8(7), e67325. 
doi:10.1371/journal. pone.0067325 
 
Van Houdt, S., & De Lepeleire, J. (2010). Does the use of care plans improve the quality of 
home care? Quality in Primary Care, 18(3), 161–172. 
 
Vernooij-Dassen, M., Draskovic, I., McCleery, J., & Downs, M. (2011). Cognitive reframing 
for carers of people with dementia. Cochrane Database of Systematic Reviews, (11), 
CD005318. doi:10.1002/14651858.CD005318.pub2 
 
Vernooij-Dassen, M., Leatherman, S., & Rikkert, M.O. (2011). Quality of care in frail older 
people: The fragile balance between receiving and giving. British Medical Journal, 342, 
d403. 
 
Voigt-Radloff, S., Graff, M., Leonhart, R., Hull, M., Rikkert, M.O., & Vernooij-Dassen, M. 
(2011). Why did an effective Dutch complex psycho-social intervention for people with 
dementia not work in the German healthcare context? Lessons learnt from a process 
evaluation alongside a multicentre RCT. BMJ Open, 1(1), e000094. doi:10.1136/bmjopen- 
2011-000094 
 
Waldorff, F.B., Buss, D.V., Eckermann, A., Rasmussen, M.L., Keiding, N., Rishoj, S., . . . 
Waldemar, G. (2012). Efficacy of psychosocial intervention in patients with mild Alzheimer’s 
disease: The multicentre, rater blinded, randomised Danish Alzheimer Intervention Study 
(DAISY). British Medical Journal, 17(345), e4693. doi:10.1136/bmj. e4693 
 
Wenborn, J., Challis, D., Head, J., Miranda-Castillo, C., Popham, C., Thakur, R., . . . Orrell, 
M. (2013). Providing activity for people with dementia in care homes: A cluster randomised 
controlled trial. International Journal of Geriatric Psychiatry, 28(12), 1296–1304. 
doi:10.1002/gps.3960  
 
Wimo, A., Jonsson, L., Bond, J., Prince, M., Winblad, B., & Alzheimer Disease, I. (2013). 
The worldwide economic impact of dementia 2010. [Research Support, Non-U.S. Gov’t]. 
Alzheimer’s & Dementia, 9(1), 1–11, e13.  doi:10.1016/j.jalz.2012.11.006 
 
Woods, B., Aguirre, E., Spector, A.E., & Orrell, M. (2012). Cognitive stimulation to improve 
cognitive functioning in people with dementia. Cochrane Database of Systematic Reviews, 2, 
CD005562. doi:10.1002/14651858.CD005562.pub2 [doi] 
 
Zwarenstein, M., Treweek, S., Gagnier, J.J., Altman, D.G., Tunis, S., Haynes, B., . . . 
Pragmatic Trials in Healthcare (Practihc) groups. (2008). Improving the reporting of 
pragmatic trials: An extension of the CONSORT statement. British Medical Journal, 337, 
a2390. doi:10.1136/bmj.a2390 
 
 
 
Myrra Vernooij-Dassen 
Radboud University Nijmegen Medical Centre, 
IQ Healthcare, Nijmegen, The Netherlands 
Email: Myrra.Vernooij-Dassen@Radboudumc.nl 
 
Esme Moniz-Cook 
University of Hull, Clinical Psychology & Ageing, 
Coltman Street Day Hospital, Hull, UK 
